(Q33472027)

27 July 2017

1 reference

title

Quantitative imaging biomarkers in neuro-oncology (English)

1 reference

27 July 2017

0 references

Stephen J Price

3

0 references

Adam D Waldman

Adam D Waldman

1

0 references

David J Collins

David J Collins

8

0 references

Paul S Tofts

Paul S Tofts

7

0 references

Dorothee P. Auer

Dorothee P Auer

6

0 references

Martin Leach

Martin O Leach

9

0 references

author name string

Alan Jackson

2

1 reference

27 July 2017

Christopher A Clark

4

1 reference

27 July 2017

Thomas C Booth

5

1 reference

27 July 2017

Jeremy H Rees

10

1 reference

27 July 2017

National Cancer Research Institute Brain Tumour Imaging Subgroup

11

1 reference

27 July 2017

language of work or name

English

0 references

publication date

23 June 2009

1 reference

Nature Reviews Clinical Oncology

27 July 2017

1 reference

27 July 2017

6

1 reference

27 July 2017

8

1 reference

27 July 2017

445-454

1 reference

Effect of hydrophilic components of the extracellular matrix on quantifiable diffusion-weighted imaging of human gliomas: preliminary results of correlating apparent diffusion coefficient values and hyaluronan expression level

27 July 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Distinction between cerebral abscesses and high-grade neoplasms by dynamic susceptibility contrast perfusion MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Differentiating surgical from non-surgical lesions using perfusion MR imaging and proton MR spectroscopic imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

11C-methionine PET for differential diagnosis of low-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Diffusion tensor imaging: possible implications for radiotherapy treatment planning of patients with high-grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Early change in glucose metabolic rate measured using FDG-PET in patients with high-grade glioma predicts response to temozolomide but not temozolomide plus radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Comparison of diameter and perimeter methods for tumor volume calculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Automated classification of short echo time in in vivo 1H brain tumor spectra: a multicenter study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Using pattern analysis of in vivo proton MRSI data to improve the diagnosis and surgical management of patients with brain tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Classification of brain tumours using short echo time 1H MR spectra

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Pitfalls in the diagnosis of brain tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Discrimination of capsular stage brain abscesses from necrotic or cystic neoplasms using diffusion-weighted magnetic resonance imaging.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Differential MRI diagnosis between brain abscesses and necrotic or cystic brain tumors using the apparent diffusion coefficient and normalized diffusion-weighted images

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Brain abscess and cystic brain tumor: discrimination with dynamic susceptibility contrast perfusion-weighted MRI.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Importance of diffusion-weighted imaging in the diagnosis of cystic brain tumors and intracerebral abscesses.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Spectroscopic magnetic resonance imaging of a tumefactive demyelinating lesion.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Vascular endothelial growth/permeability factor expression in human glioma specimens: correlation with vasogenic brain edema and tumor-associated cysts.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Diffusion-Tensor MR Imaging of Intracranial Neoplasia and Associated Peritumoral Edema: Introduction of the Tumor Infiltration Index

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Apparent diffusion coefficient histograms may predict low-grade glioma subtype.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

MR spectroscopy of brain tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Contribution of dynamic contrast MR imaging to the differentiation between dural metastasis and meningioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Diffusion MR imaging in glioma: does it have any role in the pre-operation determination of grading of glioma?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Can proton MR spectroscopic and perfusion imaging differentiate between neoplastic and nonneoplastic brain lesions in adults?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Diffusion tensor imaging of brain tumours at 3T: a potential tool for assessing white matter tract invasion?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Volumes and growth rates of untreated adult low-grade gliomas indicate risk of early malignant transformation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Imaging correlates of molecular signatures in oligodendrogliomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

The use of magnetic resonance imaging to noninvasively detect genetic signatures in oligodendroglioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Diffusion-tensor imaging of white matter tracts in patients with cerebral neoplasm.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

White matter fiber tracking in patients with space-occupying lesions of the brain: a new technique for neurosurgical planning?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Preoperative and intraoperative diffusion tensor imaging-based fiber tracking in glioma surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Motor and language DTI Fiber Tracking combined with intraoperative subcortical mapping for surgical removal of gliomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Identification of the sensorimotor cortex with functional MRI: frequency and actual contribution in a neurosurgical context

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Cortical language localization in left, dominant hemisphere. An electrical stimulation mapping investigation in 117 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Presurgical functional MR imaging of language and motor functions: validation with intraoperative electrocortical mapping.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Metabolic and electrophysiological validation of functional MRI

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Language functional magnetic resonance imaging in preoperative assessment of language areas: correlation with direct cortical stimulation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Reproducibility of fMRI-determined language lateralization in individual subjects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Proton magnetic resonance spectroscopy imaging in the evaluation of patients undergoing gamma knife surgery for Grade IV glioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Optic radiation tractography integrated into simulated treatment planning for Gamma Knife surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Response criteria for phase II studies of supratentorial malignant glioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

The effect of bevacizumab (Avastin) on neuroimaging of brain metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Blood oxygenation level-dependent MRI of cerebral gliomas during breath holding.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Potential significance of (11)C-methionine PET as a marker for the radiosensitivity of low-grade gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Metabolic and molecular imaging in neuro-oncology.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Quantitative assessment of intracranial tumor response to dexamethasone using diffusion, perfusion and permeability magnetic resonance imaging.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.92

Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin.

31 March 2020

1 reference

12 December 2020

Pseudo-reorganization of language cortical function at fMR imaging: a consequence of tumor-induced neurovascular uncoupling.

1 reference

12 December 2020

Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].

1 reference

12 December 2020

Proton magnetic resonance spectroscopic imaging integrated into image-guided surgery: correlation to standard magnetic resonance imaging and tumor cell density

1 reference

12 December 2020

Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery

1 reference

12 December 2020

Measurement of tumor "size" in recurrent malignant glioma: 1D, 2D, or 3D?

1 reference

12 December 2020

High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas.

1 reference

12 December 2020

Dynamic contrast-enhanced perfusion MR imaging measurements of endothelial permeability: differentiation between atypical and typical meningiomas.

1 reference

12 December 2020

Comparison of microvascular permeability measurements, K(trans), determined with conventional steady-state T1-weighted and first-pass T2*-weighted MR imaging methods in gliomas and meningiomas.

1 reference

12 December 2020

Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies

1 reference

12 December 2020

Value of dynamic susceptibility contrast magnetic resonance imaging in the evaluation of intracranial tumors

1 reference

12 December 2020

A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors.

1 reference

12 December 2020

Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography?

1 reference

12 December 2020

Is volume transfer coefficient (K(trans)) related to histologic grade in human gliomas?

1 reference

12 December 2020

Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue.

1 reference

12 December 2020

Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.

1 reference

12 December 2020

Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging

1 reference

12 December 2020

Assessment of functional MR imaging in neurosurgical planning.

1 reference

12 December 2020

Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions.

1 reference

12 December 2020

MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas.

1 reference

12 December 2020

Diffusion-weighted MR of the brain: methodology and clinical application.

1 reference

12 December 2020

Appearance of meningiomas on diffusion-weighted images: correlating diffusion constants with histopathologic findings.

1 reference

12 December 2020

Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging

1 reference

12 December 2020

10.1038/NRCLINONC.2009.92

Identifiers

DOI

1 reference

27 July 2017

1 reference